Potomac Fund Management Inc /Adv Astrazeneca PLC Transaction History
Potomac Fund Management Inc /Adv
- $2.36 Trillion
- Q3 2025
A detailed history of Potomac Fund Management Inc /Adv transactions in Astrazeneca PLC stock. As of the latest transaction made, Potomac Fund Management Inc /Adv holds 21,523 shares of AZN stock, worth $1.92 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
21,523
Previous 21,708
0.85%
Holding current value
$1.92 Million
Previous $1.52 Billion
8.54%
% of portfolio
0.07%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...